Literature DB >> 8360656

Parkinson's Disease Society Brain Bank, London: overview and research.

S E Daniel1, A J Lees.   

Abstract

The UK Parkinson's Disease Society Brain Bank receives tissue from patients with Parkinson's disease and a variety of different movement disorders. Half of the brain is used for full neuropathological examination prior to allocation for specific research projects. Clinical misdiagnosis occurs in a significant proportion of cases and clinico-pathological correlation provides valuable information for disease recognition. With the expanding number of other specialist brain banks there is a need for agreement on diagnostic criteria. Furthermore, awareness of different methods of tissue handling is essential.

Entities:  

Mesh:

Year:  1993        PMID: 8360656

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  165 in total

1.  The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval.

Authors:  Alexander Zimprich; Bertram Müller-Myhsok; Matthew Farrer; Petra Leitner; Manu Sharma; Mary Hulihan; Paul Lockhart; Audrey Strongosky; Jennifer Kachergus; Donald B Calne; Jon Stoessl; Ryan J Uitti; Ronald F Pfeiffer; Claudia Trenkwalder; Nikolaus Homann; Erwin Ott; Karoline Wenzel; Friedrich Asmus; John Hardy; Zbigniew Wszolek; Thomas Gasser
Journal:  Am J Hum Genet       Date:  2003-12-19       Impact factor: 11.025

Review 2.  Co-existence of Parkinson's disease and progressive supranuclear palsy: case report and a review of the literature.

Authors:  Kumar Abhinav; Laura Marsh; Barbara Crain; Stephen G Reich; Kevin Biglan
Journal:  Neurol Sci       Date:  2010-08-25       Impact factor: 3.307

3.  Gray matter atrophy in patients with Parkinson's disease and those with mild cognitive impairment: a voxel-based morphometry study.

Authors:  Jing Zhang; Yun-Ting Zhang; Wei-Dong Hu; Li Li; Guang-Yao Liu; Yu-Ping Bai
Journal:  Int J Clin Exp Med       Date:  2015-09-15

4.  Microglial exosomes facilitate α-synuclein transmission in Parkinson's disease.

Authors:  Min Guo; Jian Wang; Yanxin Zhao; Yiwei Feng; Sida Han; Qiang Dong; Mei Cui; Kim Tieu
Journal:  Brain       Date:  2020-05-01       Impact factor: 13.501

5.  The effect of levodopa therapy on dopamine transporter SPECT imaging with( 123)I-FP-CIT in patients with Parkinson's disease.

Authors:  Orazio Schillaci; Mariangela Pierantozzi; Luca Filippi; Carlo Manni; Livia Brusa; Roberta Danieli; Giorgio Bernardi; Giovanni Simonetti; Paolo Stanzione
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-09-08       Impact factor: 9.236

6.  Hallucinosis in idiopathic Parkinson's disease.

Authors:  J M Graham; R A Grünewald; H J Sagar
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-10       Impact factor: 10.154

7.  Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia.

Authors:  Blanca Ramírez-Ruiz; María José Martí; Eduardo Tolosa; David Bartrés-Faz; Chistopher Summerfield; Pilar Salgado-Pineda; Beatriz Gómez-Ansón; Carme Junqué
Journal:  J Neurol       Date:  2005-07-05       Impact factor: 4.849

8.  Cardiovascular variability in Parkinson's disease and extrapyramidal motor slowing.

Authors:  Rachael Brown; Stephen Duma; Olivier Piguet; G Anthony Broe; Vaughan G Macefield
Journal:  Clin Auton Res       Date:  2012-04-25       Impact factor: 4.435

9.  Visual assessment of dopaminergic degeneration pattern in 123I-FP-CIT SPECT differentiates patients with atypical parkinsonian syndromes and idiopathic Parkinson's disease.

Authors:  Deniz Kahraman; Carsten Eggers; Harald Schicha; Lars Timmermann; Matthias Schmidt
Journal:  J Neurol       Date:  2011-07-13       Impact factor: 4.849

10.  Onset age and severity of motor impairment are associated with reduction of myocardial 123I-MIBG uptake in Parkinson's disease.

Authors:  K Hamada; M Hirayama; H Watanabe; R Kobayashi; H Ito; T Ieda; Y Koike; G Sobue
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.